News

VIDEO: What explains SYMPLICITY HTN-3’s failure?

Posted on: 29/03/2014 - 21:55

WASHINGTON  – What can explain the failure of SYMPLICITY HTN-3? After clinical success in reducing blood pressure by 20-30 mm HG in patients with resistant hypertension, the renal denervation...

Field of Interest: Cardiology
Type: News Item

Diet drinks linked to CVD in women

Posted on: 29/03/2014 - 12:00

Drinking two or more diet drinks a day was associated with a 29% increased risk of an incident cardiovascular event and a 26% increased risk of all-cause death compared with less diet drink...

Field of Interest: Pulmonology
Type: News Item

Diet drinks linked to CVD in women

Posted on: 29/03/2014 - 12:00

Drinking two or more diet drinks a day was associated with a 29% increased risk of an incident cardiovascular event and a 26% increased risk of all-cause death compared with less diet drink...

Field of Interest: Cardiology
Type: News Item

Meta-analysis shows statins help erectile function

Posted on: 29/03/2014 - 12:00

Men with erectile dysfunction had a better than threefold improvement in erectile function after receiving statin treatment compared with men randomized to placebo in a meta-analysis of 11 controlled...

Field of Interest: Cardiology
Type: News Item

Novel anticoagulants get nod in new AF guidelines

Posted on: 28/03/2014 - 18:45

New guidelines for managing patients with nonvalvular atrial fibrillation recommend dabigatran, rivaroxaban, and apixaban, as well as warfarin, and call on physicians to use a more comprehensive...

Field of Interest: Cardiology
Type: News Item

Ustekinumab again linked to cardiovascular events

Posted on: 28/03/2014 - 17:05

WAIKOLOA, HAWAII – The anti-interleukin-12/23 biologic agents ustekinumab and briakinumab were associated with a statistically significant 4.23-fold increased risk of major adverse cardiac events in...

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More